Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials

Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials

Anticoagulation, reducing the risk of thromboembolic events in patients undergoing cardioversion, is a cornerstone of peri-cardioversion management in patients with atrial fibrillation. We aimed to analyse published data on the efficacy and safety of direct oral anticoagulants (DOACs) in patients u...

Full description

Bibliographic Details
Main Authors:	Stefania Angela Di Fusco, Furio Colivicchi, Nadia Aspromonte, Marco Tubaro, Alessandro Aiello, Massimo Santini
Format:	Article
Language:	English
Published:	PAGEPress Publications 2017-05-01
Series:	Monaldi Archives for Chest Disease
Subjects:	Oral anticoagulants atrial fibrillation cardioversion randomized clinical trials.
Online Access:	https://www.monaldi-archives.org/index.php/macd/article/view/805

Similar Items

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
by: Fabiana Lucà, et al.
Published: (2021-07-01)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
by: Amgad Mentias, et al.
Published: (2021-09-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
by: Giuseppe Coppola, et al.
Published: (2019-09-01)

THE IMPORTANCE OF EARLY CARDIOVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
by: Franc Verovnik
Published: (2002-01-01)

Clinical experience of dabigatran and rivaroxaban in electrical cardioversion of atrial fibrillation
by: Charlène Coquard, et al.
Published: (2015-01-01)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019-05-01)

Comparison of Effectiveness and Safety of Antiarrhythmic Drugs Class IC and III in Patients After Electrical Cardioversion
by: Strēlnieks Aldis, et al.
Published: (2019-03-01)

Non-vitamin K antagonist oral anticoagulants versus warfarin for cardioversion of atrial fibrillation in clinical practice: A single-center experience
by: Naoki Shibata, MD, et al.
Published: (2017-02-01)

Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial
by: Gregory Y. H. Lip, et al.
Published: (2020-06-01)

Diagnosis and Management of Left Atrium Appendage Thrombosis in Atrial Fibrillation Patients Undergoing Cardioversion
by: Enrico Melillo, et al.
Published: (2019-08-01)

Current Status of Internal Cardioversion in Atrial Fibrillation.
by: Andreas Plewan, et al.
Published: (2002-04-01)

Cardioversion for atrial fibrillation during pregnancy
by: Dodji Kossi Djakpo, et al.
Published: (2019-06-01)

Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm
by: Amine El Amrani, et al.
Published: (2021-03-01)

Initial Energy for External Electrical Cardioversion of Atrial Fibrillation
by: Edilberto Figueiredo, et al.
Published: (2002-08-01)

Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation -- a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study)
by: Farkowski Michal M, et al.
Published: (2012-09-01)

Cardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversion
by: Ibrahim Altun, et al.
Published: (2015-07-01)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
by: Niklas Höglund, et al.
Published: (2017-04-01)

Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis
by: Loffredo Lorenzo, et al.
Published: (2012-11-01)

External electrical cardioversion of persistent atrial fibrillation in a patient with a Micra™ Transcatheter Pacing System
by: K. Filipovic, et al.
Published: (2018-01-01)

Atrial mechanical hypofunction after electrical cardioversion of persistent or long-lasting persistent atrial fibrillation: a retrospective cohort study
by: Renato De Vecchis, et al.
Published: (2019-12-01)

Upstream Statin Therapy and Long-Term Recurrence of Atrial Fibrillation after Cardioversion: A Propensity-Matched Analysis
by: Lukas Fiedler, et al.
Published: (2021-02-01)

Outcomes of hospitalizations with atrial fibrillation-flutter on a weekday versus weekend: an analysis from a 2014 nationwide inpatient sample
by: Dinesh C. Voruganti, et al.
Published: (2019-01-01)

Where will non-Vitamin K oral anticoagulants stand beyond being standard of care in anticoagulation therapy?
by: Oktay Ergene
Published: (2019-01-01)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01)

Electrical Cardioversion in Atrial Fibrillation: Success Rates
by: JRMC Admin, et al.
Published: (2018-09-01)

Efficacy and Safety of Bepridil for Patients with Persistent Atrial Fibrillation after Failed Electrical Cardioversion
by: Yasuyuki Egami, MD, et al.
Published: (2011-01-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2019-01-01)

Propofol for sedation for direct current cardioversion
by: Bruna Galvão de Wafae, et al.
Published: (2019-01-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion.
by: K. А. Pysarevska
Published: (2016-03-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion
by: Pysarevska K.О.
Published: (2016-03-01)

When the Heart Triggers the Esophagus: Esophageal Spasm after Electrical Cardioversion
by: Riccardo Manfredo Campaner, et al.
Published: (2019-12-01)

Value of transoesophageal echocardiography-guided approach to electrical cardioversion of atrial fibrillation
by: O. S. Kalashnikovа
Published: (2013-06-01)

The significance of the left atrial volume index in prediction of atrial fibrillation recurrence after electrical cardioversion
by: Mehrnoush Toufan, et al.
Published: (2017-03-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

How to Manage Atrial Fibrillation in the Emergency Department: a Critical Appraisal
by: Rafael Thiesen Magliari, et al.
Published: (2020-06-01)

Model for predicting long-term sinus rhythm retention after electrical cardioversion in patients with persistent atrial fibrillation.
by: K. O. Pysarevska, et al.
Published: (2017-12-01)

The Impact of Personal Thoracic Impedance on Electrical Cardioversion in Patients with Atrial Arrhythmias
by: Seung-Young Roh, et al.
Published: (2021-06-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2018-11-01)

Vernakalant Use in Cardioversion of Recent Onset Atrial Fibrillation: A Case Report
by: Niković Vuk, et al.
Published: (2018-09-01)